|
“Our goal is to harness the power of Nutritional Genomics.
We aim to understand genetic variations in the metabolism
of specific nutrients, beginning with L-Arginine, and to
develop methodologies specifically addressing and ameliorating
genetic variants.”
|
|
|
“Dr. Ann de Wees Allen is a pioneer and internationally
respected visionary in her field. I am delighted to have
the opportunity to join her in the Encode ® effort to
harvest the fruits of the Human Genome Project and optimize
human health through the new science of Nutritional Genomics”
|
Clair
Francomano, M.D.
Chief of Genetics
Encode® Research Project |
|
|
| |
“Encode ® is being hailed as one of the most
important and significant research projects in the field
of human health. Imagine being able to treat Sickle Cell
Disease and Thalassemia with a cherry-drink that has no
side effects and no chemicals. So many children suffer with
these diseases globally – it is for them that we strive
to find solutions hidden within the DNA.”
|
Dr.
Ann de Wees Allen
Chief of Research
Encode® Research Project |
|
Genetic
Breakthrough
Announced by Medical Community
Top Researchers Break the Code to Genetic
Diseases Sickle Cell & Thalassemia
|
|
 |
A
group of top scientists, named “The Dream Team”
have discovered the Key Code to a new treatment for
Sickle Cell Disease and Thalassemia, the number one genetic
disease in the world.
Fellow researchers named the group The Dream Team due to their
groundbreaking research and discoveries in the field of NutraGenomics.
|
|
| Touted
globally as one of the most important discoveries of this century,
researchers say that “This discovery may well be worthy of
the Nobel Prize in Medicine.”
 |
Clair
Francomano, M.D. |
|
| |
| •
|
Former
Chief of Medical Genetics at the National Institutes of Health
(NIH) |
| •
|
Former
Clinical Director, National Human Genome Research Institute |
| •
|
Former
Chief of Human Genetics for the Laboratory of Genetics at
the National Institute on Aging |
| •
|
Fellowship
in Medical Genetics, Johns Hopkins University School of Medicine |
| •
|
Associate
Professor, Johns Hopkins University School of Medicine |
|
Dr.
Ann de Wees Allen |
|
| |
| •
|
Chief
of Biomedical Research at the Glycemic Research Institute
in Washington, D.C., |
| •
|
Named the
World’s Leading L-Arginine Researcher |
| •
|
Received
the first Glycemic Patent ever awarded |
| •
|
Discovered
that L-Arginine is a Blind Amino Acid ® |
| •
|
Patents
Held: L-Arginine Biochemistry and Safe L-Arginine in Humans |
| • |
25-years
of research in the field of L-Arginine biochemistry |
| • |
Conducts
Human In Vivo Clinical Trials for the U.S. Government, as
well as the largest food companies in the world, including
Proctor & Gamble and Hershey Foods, |
| • |
Who’s
Who of American Inventors |
|
 |
|
Research
& Branches of Medicine Funded by:
www.BRSEI.org
Biomedical Research &
Science Education Institute
Discovering the Human Element |
Encode®
Patents Pending in Genetic Polymorphisms
|
|
